Immunologics for Migraine Prophylaxis

Migraines affect more than 38 million people in the US – an estimated 12% of the adult population. For some time, multi-purpose drugs like blood pressure medications, antidepressants, anti-seizure drugs, and botox injections have been used to prevent attacks. However, not developed specifically for migraine, these methods have been met with mixed results. In 2018, new medications arrived on the scene to help head off migraine pain. The class of drugs works by blocking the activity of a molecule called calcitonin gene-related peptide (CGRP), which spikes during a migraine. Actively prescribed in 2020 with no signs of slowing adoption in 2021, this new FDA-approved class of medication for migraine sufferers is helping countless individuals reclaim their personal and professional lives.